Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia

Journal of Inherited Metabolic Disease

Volumn 35, Issue 6, 2012, Pages 1119-1128

  Michot, Caroline ^a   Hubert, Laurence ^a   Romero, Norma B ^b   Gouda, Amr ^c   Mamoune, Asmaa ^a   Mathew, Suja ^d   Kirk, Edwin ^e   Viollet, Louis ^a   Rahman, Shamima ^f,j   Bekri, Soumeya ^g   Peters, Heidi ^h   McGill, James ⁱ   Glamuzina, Emma ^j   Farrar, Michelle ^k   Von Der Hagen, Maya ^l   Alexander, Ian E ^m   Kirmse, Brian ⁿ   Barth, Magalie ^o   Laforet, Pascal ^p   Benlian, Pascale ^q   Munnich, Arnold ^a   Jeanpierre, Marc ^r   Elpeleg, Orly ^s   Pines, Ophry ^t   Delahodde, Agnès ^u   De Keyzer, Yves ^a   De Lonlay, Pascale ^a,v   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e SYDNEY CHILDREN'S HOSPITAL   (Australia)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g ROUEN UNIVERSITY HOSPITAL   (France)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ ROYAL CHILDREN'S HOSPITAL   (Australia)

^j GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

^l DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^m CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

ⁿ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^o ANGERS UNIVERSITY HOSPITAL   (France)

^p ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^q Cochin Hospital ^*  (France)

^r université Paris Cité   (France)

^s HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^t HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^u UNIVERSITÉ PARIS SACLAY   (France)

^v Reference Center of Metabolic Disease   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CREATINE KINASE; FAT DROPLET; GENOMIC DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; EXERCISE; EXERCISE INDUCED MYALGIA; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC COMPLEMENTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LIPIN 1 GENE; LIPIN 2 GENE; LIPIN 3 GENE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUSCLE BIOPSY; MYALGIA; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; RHABDOMYOLYSIS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, COMPLEMENTARY; EXERCISE; FEMALE; GENES, RECESSIVE; GENETIC COMPLEMENTATION TEST; HUMANS; INFANT; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; NUCLEAR PROTEINS; PHOSPHATIDATE PHOSPHATASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RHABDOMYOLYSIS; YOUNG ADULT;

EID: 84867887549     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9461-6     Document Type: Article

References (42)

1. Adeyo O, Horn PJ, Lee S, et al.(2011) The yeast lipin orthologue Pah1p is important for biogenesis of lipid droplets. J Cell Biol 192:1043-1055
2. Bou Khalil M, Sundaram M, Zhang HY, et al.(2009) The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. J Lipid Res 50:47-58
3. Bruno C, Dimauro S (2008) Lipid storage myopathies. Curr Opin Neurol 21:601-606
4. de Lonlay-Debeney P, Edery P, Cormier-Daire V, et al.(1999) Respiratory chain deficiency presenting as recurrent myoglobinuria in childhood. Neuropediatrics 30:42-44
5. DiMauro S, Garone C, Naini A (2010) Metabolic myopathies. Curr Rheumatol Rep 12:386-393
6. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K (2007) Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 282:3450-3457
7. Donkor J, Sparks LM, Xie H, Smith SR, Reue K (2008) Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab 93:233-239
8. Donkor J, Zhang P, Wong S, et al.(2009) A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J Biol Chem 284:29968-29978
9. Fawcett KA, Grimsey N, Loos RJ, et al.(2008) Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. Populations. Diabetes 57:2527-2533
10. Ferguson PJ, Chen S, Tayeh MK, et al.(2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551-557
11. Finck BN, Gropler MC, Chen Z, et al.(2006) Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 4:199-210
12. Fischer J, Lefevre C, Morava E, et al.(2007) The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 39:28-30
13. Han GS, Carman GM (2010) Characterization of the human LPIN1-encoded phosphatidate phosphatase isoforms. J Biol Chem 285:14628-14638
14. Han GS, Wu WI, Carman GM (2006) The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem 281:9210-9218
15. Han GS, Siniossoglou S, Carman GM (2007) The cellular functions of the yeast lipin homolog PAH1p are dependent on its phosphatidate phosphatase activity. J Biol Chem 282:37026-37035
16. Harris TE, Huffman TA, Chi A, et al.(2007) Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem 282:277-286
17. Higashida K, Higuchi M, Terada S (2008) Potential role of lipin-1 in exercise-induced mitochondrial biogenesis. Biochem Biophys Res Commun 374:587-591
18. Laforet P, Vianey-Saban C (2010) Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromuscul Disord 20:693-700
19. Liang WC, Nishino I (2010) State of the art in muscle lipid diseases. Acta Myol 29:351-356
20. Liu GH, Qu J, Carmack AE, et al.(2010) Lipin proteins form homo- and hetero-oligomers. Biochem J 432:65-76
21. Loos RJ, Rankinen T, Perusse L, Tremblay A, Despres JP, Bouchard C (2007) Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring) 15:2723-2732
22. Lu B, Lu Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2008) LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 295:E1502-E1509
23. Michot C, Hubert L, Brivet M, et al.(2010) LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. Hum Mutat
24. Mul JD, Nadra K, Jagalur NB, et al.(2011) A hypomorphic mutation in Lpin1 induces progressively improving neuropathy and lipodystrophy in the rat. J Biol Chem 286:26781-26793
25. Nakajima Y, Masaoka N, Tsuduki Y, Honda N, Sakai M (2011) Rhabdomyolysis caused by tocolytic therapy with oral ritodrine hydrochloride in a pregnant woman with placenta previa. J Obstet Gynaecol Res
26. Ohkuma A, Noguchi S, Sugie H, et al.(2009) Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve 39:333-342
27. Peterfy M, Phan J, Xu P, Reue K (2001) Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 27:121-124
28. Peterfy M, Phan J, Reue K (2005) Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem 280:32883-32889
29. Possekel S, Lombes A, Ogier de Baulny H, et al.(1995) Immunohistochemical analysis of muscle cytochrome c oxidase deficiency in children. Histochem Cell Biol 103:59-68
30. Reue K, Brindley DN (2008) Thematic review series: glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J Lipid Res 49:2493-2503
31. Reue K, Zhang P (2008) The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett 582:90-96
32. Sarullo FM, Americo L, Di Franco A, Di Pasquale P (2010) Rhabdomyolysis induced by co-administration of fluvastatin and colchicine. Monaldi Arch Chest Dis 74:147-149
33. Shek A, Ferrill MJ (2001) Statin-fibrate combination therapy. Ann Pharmacother 35:908-917
34. Sugden MC, Caton PW, Holness MJ (2010) PPAR control: it's SIRTainly as easy as PGC. J Endocrinol 204:93-104
35. Tsuchiya Y, Takahashi N, Yoshizaki T, et al.(2009) A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 382:348-352
36. Ucar M, Mjorndal T, Dahlqvist R (2000) HMG-CoA reductase inhibitors and myotoxicity. Drug Saf 22:441-457
37. van Adel BA, Tarnopolsky MA (2009) Metabolic myopathies: update 2009. J Clin Neuromuscul Dis 10:97-121
38. Wang H, Zhang J, Qiu W, Han GS, Carman GM, Adeli K (2011) Lipin-1gamma isoform is a novel lipid droplet-associated protein highly expressed in the brain. FEBS Lett 585:1979-1984
39. Wiedmann S, Fischer M, Koehler M, et al.(2008) Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57:209-217
40. Yao-Borengasser A, Rasouli N, Varma V, et al.(2006) Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 55:2811-2818
41. Zeharia A, Shaag A, Houtkooper RH, et al.(2008) Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet 83:489-494
42. Zhou J, Young TL (2005) Evaluation of Lipin 2 as a candidate gene for autosomal dominant 1 high-grade myopia. Gene 352:10-19